Comments

Rigel Pharmaceuticals Stock Guidance

RIGLNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$42.48

1.704.17%

At close: Dec 15, 4:00 PM EST

$40.97

-1.51-3.55%

After Hours: 8:37 AM EST

Overview News Earnings Options

Guidance

Analyst Ratings Insider Trades Short Interest Stock Report

Rigel Pharmaceuticals Stock Guidance | NASDAQ:RIGL | Benzinga

Rigel Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
11/04/2025	RIGL	Rigel Pharmaceuticals	FY	2025	—	—	—	$285.00M	$290.00M	$281.00M	Get Alert
08/05/2025	RIGL	Rigel Pharmaceuticals	FY	2025	—	—	—	$210.00M	$220.00M	$228.73M	Get Alert
05/06/2025	RIGL	Rigel Pharmaceuticals	FY	2025	—	—	—	$200.00M	$210.00M	$197.79M	Get Alert
03/04/2025	RIGL	Rigel Pharmaceuticals	FY	2025	—	—	—	$200.00M	$210.00M	$204.88M	Get Alert
01/13/2025	RIGL	Rigel Pharmaceuticals	FY	2025	—	—	—	$200.00M	$210.00M	$193.51M	Get Alert
01/13/2025	RIGL	Rigel Pharmaceuticals	Q4	2024	—	—	—	$57.60M	$57.60M	$47.42M	Get Alert
01/13/2025	RIGL	Rigel Pharmaceuticals	FY	2024	—	—	—	$179.30M	$179.30M	$169.10M	Get Alert
01/08/2024	RIGL	Rigel Pharmaceuticals	Q4	2023	—	—	—	$35.70M	$35.70M	$29.78M	Get Alert
01/09/2023	RIGL	Rigel Pharmaceuticals	Q4	2022	—	—	—	$51.30M	$51.30M	$21.65M	Get Alert
01/10/2022	RIGL	Rigel Pharmaceuticals	Q4	2021	—	—	—	$20.40M	$20.40M	$23.39M	Get Alert

FAQ

Q

What is the most recent guidance for Rigel Pharmaceuticals (RIGL)?

A

There have been no specific sales or earnings guidance reported for Rigel Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

KalVista Pharmaceuticals Inc

CytomX Therapeutics Inc

Gyre Therapeutics Inc

Replimune Group Inc

Cullinan Therapeutics Inc

Lexeo Therapeutics Inc

Lyell Immunopharma Inc